Patient Pathfinder: Clinical Trials
Clinical Trials for Multiple Myeloma
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 515 active Multiple Myeloma trials
Scalp Cooling to Prevent Hair Loss in Patients Undergoing Stem Cell Transplantation for Multiple Myeloma
Study Type: Interventional
Limited-duration Teclistamab
Study Type: Interventional Phase 2
PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma
Study Type: Interventional
Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant
Study Type: Interventional Phase 3
International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab
Study Type: Interventional Phase 2
Elimination of Minimal Residual Disease After Transplant
Study Type: Interventional Phase 2
Evaluation of Comprehensive Geriatric Assessment and Laboratory Biomarkers in Elderly Patients With Multiple Myeloma
Study Type: Observational
Isa-Pom-Dex in Elderly/Frail Subjects With RRMM
Study Type: Interventional Phase 2
There are 515 active Multiple Myeloma trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now